Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Physical Fatigue Through the Perspective of Immunosenescence
Authors:
- 29 September 2025
- journal article
- review article
- Published by Wiley in Comprehensive Physiology
- Vol. 15 (5) , e70056
Abstract
Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating illness marked by persistent fatigue, yet its mechanisms remain unclear. Growing evidence implicates immunosenescence—the age‐related decline in immune function—in the onset and persistence of fatigue. Methods: This review synthesizes clinical and experimental data to examine how immunosenescence contributes to ME/CFS. We focus on chronic inflammation, senescent immune phenotypes, mitochondrial dysfunction, and neuroendocrine imbalance, with emphasis on maladaptive crosstalk among immune, muscular, neuroendocrine, and vascular systems. Results: Aging immune cells drive chronic inflammation that impairs mitochondrial ATP production and promotes muscle catabolism. Concurrently, HPA‐axis suppression and β 2 ‐adrenergic dysfunction amplify immune dysregulation and energy imbalance. Together, these processes illustrate how immunosenescence sustains pathological cross‐organ signaling underlying systemic fatigue. Conclusion: Immunosenescence provides a unifying framework linking immune, metabolic, and neuroendocrine dysfunction in ME/CFS. Recognizing cross‐organ communication highlights its clinical relevance, suggesting biomarkers such as cytokines and exhaustion markers, and supports integrated therapeutic strategies targeting immune and metabolic networks.Keywords
This publication has 117 references indexed in Scilit:
- Key Pathophysiological Role of Skeletal Muscle Disturbance in Post COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Accumulated EvidenceJournal of Cachexia, Sarcopenia and Muscle, 2024
- Chronic stimulation desensitizes β2‐adrenergic receptor responses in natural killer cellsEuropean Journal of Immunology, 2024
- Clinical and Laboratory Characteristics of Fatigue-Dominant Long-COVID Subjects: A Cross-Sectional StudyThe American Journal of Medicine, 2024
- Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?Journal of Cachexia, Sarcopenia and Muscle, 2020
- Exercise therapy for chronic fatigue syndromeCochrane Database of Systematic Reviews, 2019
- Skeletal muscle cells actively shape (auto)immune responsesAutoimmunity Reviews, 2018
- Beyond Myalgic Encephalomyelitis/Chronic Fatigue SyndromeJAMA, 2015
- B cells and immunosenescence: A focus on IgG+IgD−CD27− (DN) B cells in aged humansAgeing Research Reviews, 2011
- Lipotoxicity, fatty acid uncoupling and mitochondrial carrier functionBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Lymphocyte phenotype and function in the chronic fatigue syndromeJournal of Clinical Immunology, 1993